Biovica International AB (publ) (STO:BIOVIC.B)
Sweden · Delayed Price · Currency is SEK 0.3630
-0.0070 (-1.89%)
Jul 3, 2026, 3:54 PM CET
Biovica International AB Market Cap
Biovica International AB has a market cap or net worth of 105.09 million as of July 2, 2026. Its market cap has increased by 51.36% in one year.
Market Cap
105.09M
Enterprise Value
38.97M
Revenue
13.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.36
Market Cap Chart
Since March 29, 2017, Biovica International AB's market cap has decreased from 210.00M to 105.09M, a decrease of -49.96%. That is a compound annual growth rate of -7.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 105.09M | -2.70% |
| Dec 30, 2025 | 108.01M | -44.77% |
| Dec 30, 2024 | 195.57M | -9.82% |
| Dec 29, 2023 | 216.86M | -41.83% |
| Dec 30, 2022 | 372.79M | -68.37% |
| Dec 30, 2021 | 1.18B | -18.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Active Biotech AB | 150.78M |
| Simris Group AB (PUBL) | 132.01M |
| NextCell Pharma AB | 114.39M |
| Alligator Bioscience AB | 109.29M |
| IRLAB Therapeutics AB | 105.49M |
| OncoZenge AB | 103.82M |
| Spago Nanomedical AB | 92.61M |
| Scandinavian ChemoTech AB | 92.40M |